Palatin is a New Jersey biopharmaceutical company developing peptide and small molecule medicines that target melanocortin receptors. It last closed at $5.37 on Nov 17, down 13.53% on the day.
Only 1 firm rated PTN in the past 90 days, not enough for a consensus
Average 12-month target
$12.00
▲ 123.5% upside
Based on 1 analyst who set a price target on PTN in the past 90 days. The average target is $12.00, with a high of $12.00 and a low of $12.00, compared with the last close of $5.37.
Low $12.00Avg $12.00High $12.00
Blue marker: last close $5.37
Highest target$12.00
Average target$12.00
Lowest target$12.00
Latest rating changes
HC Wainwright & Co.Initiated
Nov 6Buy$17 → $12
HC Wainwright & Co.Reiterated
Sep 25Buy$17
Date
Firm
Action
Rating
Price target
Nov 6
HC Wainwright & Co.
Initiated
Buy
$17 → $12
Sep 25
HC Wainwright & Co.
Reiterated
Buy
$17
Loading…
Technical Analysis
PTN · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 6% below its 20 day and 47% below its 50 day average. It is 150% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 37), near oversold. The nearest support is the Pivot S1 at $5.00, and the nearest resistance the Pivot at $5.63.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 13.2%/day
Key levels
$31.0052 week high+477.3%
$13.42200 day average+149.9%
$8.75100 day average+62.9%
$7.9250 day average+47.5%
$7.33Swing high (Nov 9)+36.5%
$6.00Pivot R1+11.7%
$5.6920 day average+6.0%
$5.63Pivot+4.8%
$5.37Last close
$5.00Pivot S1−6.9%
$4.76Swing low (Nov 5)−11.4%
$4.5152 week low−16.0%
Indicators
RSI (14)
37.20
Weak, oversold below 30
Neutral
MACD
-0.37
Above its signal line
Bullish
Stochastic
48.5
Middle of its range
Neutral
ADX (14)
24.2
Weak trend
Williams %R
-75.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-6.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.9%
Change over 10 sessions
Bullish
ATR (14)
$0.71
Typical daily range, 13.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 41.8%/day
Key levels
$31.0052 week high+477.3%
$13.42200 day average+149.9%
$8.75100 day average+62.9%
$7.9250 day average+47.5%
$7.33Swing high (Nov 9)+36.5%
$6.00Pivot R1+11.7%
$5.6920 day average+6.0%
$5.63Pivot+4.8%
$5.37Last close
$5.00Pivot S1−6.9%
$4.76Swing low (Nov 5)−11.4%
$4.5152 week low−16.0%
Indicators
RSI (14)
34.29
Weak, oversold below 30
Neutral
MACD
-2.23
Below its signal line
Bearish
Stochastic
15.2
Near the bottom of its range
Oversold
ADX (14)
19.4
No clear trend
Williams %R
-90.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-108.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−54.5%
Change over 10 sessions
Bearish
ATR (14)
$2.24
Typical daily range, 41.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for PTN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PTN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow PTN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How PTN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PTN is in one of them and how their past PTN trades turned out.
Palatin is a biopharmaceutical company based in Cranbury, New Jersey. It develops drug candidates that act on the melanocortin receptor system, a group of receptors involved in inflammation, immune response, appetite and metabolism. Its main focus is treatments for obesity and rare diseases tied to this pathway, with other candidates aimed at eye, gut and immune conditions. The company generally works with pharmaceutical partners to license and commercialize its products.